The emerging therapy of the medication represents a significant development in the handling of type 2 diabetes. Unlike existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide789231.blogrelation.com/48670818/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment